Evaluation of pharmacokinetic interaction between bromfenac and phenytoin in healthy males

Journal of Clinical Pharmacology

Volumn 37, Issue 2, 1997, Pages 160-168

  Gumbhir Shah, Kavita ^a   Cevallos, William H ^a   DeCleene, Sheryl A ^a   Korth Bradley, Joan M ^a  

^a WYETH AYERST RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMFENAC; PHENYTOIN;

ADULT; ANALGESIA; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG MIXTURE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PATIENT CARE; POSTOPERATIVE PAIN;

EID: 0030985556     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1997.tb04775.x     Document Type: Article

References (28)

1. Forbes JA, Beaver WT, Jones KF, Edquist IA, Gongloff CM, Smith WK, et al: Analgesic efficacy of bromfenac, ibuprofen, and aspirin in postoperative oral surgery pain. Clin Pharmacol Ther 1992;51:343-352.
2. Nolan JC, Osman MA, Cheng LK, Sancilio LF: Bromfenac, a new nonsteroidal anti-inflammatory drug: relationship between the anti-inflammatory and analgesic activity and plasma drug levels in rodents. J Pharmacol Exp Ther 1990;254:104-108.
3. Sancilio LF, Nolan JC, Wagner LE, Ward JW: The analgesic and antiinflammatory activity and pharmacologic properties of bromfenac. Arzneimittelforschung 1987;37:513-519.
4. Forbes JA, Edquist IA, Smith FG, Schwartz MK, Beaver WT: Evaluation of bromfenac, aspirin, and ibuprofen in postoperative oral surgery pain. Pharmacotherapy 1991;11:64-70.
5. McQuay HJ, Carroll D, Frankland T, Harvey M, Moore A: Bromfenac, acetaminophen, and placebo in orthopedic postoperative pain. Clin Pharmacol Ther 1990;47:760-766.
6. Carroll D, Frankland T, Nagle C, McQuay H: Oral bromfenac 10 and 25 mg compared with sublingual buprenorphine 0.2 and 0.4 mg for postoperative pain relief. Br J Anaesth 1993;71:814-817.
7. Boström ÅAS, Forbes JA, Adolfsson C, Beaver WT, Bell WE: Evaluation of bromfenac and ibuprofen for pain after orthopedic surgery. Pharmacotherapy 1994;14:305-313.
8. Wajdula JS, Vavra I, Sullivan D, Ermer J, Osman M: Bromfenac. In, Lewis AJ, Furst DE (eds.): Nonsteroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Uses. Second edition. New York: Marcel Dekker, Inc, 1994;267-284.
9. Högger P, Rohdewald P: Pharmacokinetics of bromfenac in healthy subjects after single oral administration of three different doses. Arzneimittelforschung 1993;43:1114-1118.
10. Winship LC, Carchman SH, Clark BC, Cannon WM, Osman M, Dunning LK, Wright GJ: Pharmacokinetics and protein binding of bromfenac, a non-narcotic analgesic, in elderly male and female subjects. Pharmacotherapy 1988;8:127.
11. Carchman SH, Winship LC, Crowe JT Jr, Osman M, Dunning LK, Wright GJ: Dose proportionality and protein binding of bromfenac, a non-narcotic analgesic, in healthy male volunteers. Clin Pharmacol Ther 1988;43:148.
12. Gugler R, Manion CV, Azarnoff DL: Phenytoin: pharmacokinetics and bioavailability. Clin Pharmacol Ther 1976;19:135-142.
13. Houghton GW, Richens A, Leighton M: Effect of age, height, weight and sex on serum phenytoin concentration in epileptic patients. Br J Clin Pharmacol 1975;2:251-256.
14. Bachmann KA, Schwartz JI, Forney RB Jr, Jauregui L, Sullivan TJ: Inability of ibuprofen to alter single dose phenytoin disposition. Br J Clin Pharmacol 1986;21:165-169.
15. Perucca E: Pharmacokinetic interactions with antiepileptic drugs. Clin Pharmacokinet 1982;7:57-84.
16. Watkins PB: Drug metabolism by cytochromes-P450 in the liver and small bowel. Gastroenterology Clinics of North America 1992;21:511-526.
17. Leonard RF, Knott PJ, Rankin GO, Robinson DS, Melnick DE: Phenytoin-salicylate interaction. Clin Pharmacol Ther 1981;29: 56-60.
18. Paxton JW: Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects. Clin Pharmacol Ther 1980;27:170-178.
19. Fraser DG, Ludden TM, Evens RP, Sutherland EW: Displacement of phenytoin from plasma binding sites by salicylate. Clin Pharmacol Ther 1980;27:165-169.
20. Olanow CW, Finn AL, Prussak C: The effects of salicylate on the pharmacokinetics of phenytoin. Neurology 1981;31:341-342.
21. Inoue F, Walsh RJ: Folate supplements and phenytoin-salicylate interaction. Neurology 1983;33:115-116.
22. Osman MA, Dunning LK, Cheng LK, Wright GJ: Determination of bromfenac in plasma by high-performance liquid chromatography. J Chromatogr 1989;489:452-458.
23. Gumbhir-Shah K, Cevallos WH, DeCleene SA, Korth-Bradley JM: Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis. J Rheumatol 1996;23:984-989.
24. Boudinot DF, Jusko WJ: Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J Pharm Sci 1984;73:774-780.
25. Jusko WJ: Guidelines for collection and analysis of pharmacokinetic data. In, Evans WE, Schentag JJ, Jusko WJ (eds.): Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. Third edition. Spokane, Wash: Applied Therapeutics, 1992;2-1-2-43.
26. Vozeh S, Muir KT, Sheiner LB, Follath F: Predicting individual phenytoin dosage. J Pharmacokinet Biopharm 1981;9:131-146.
27. Osman M, Chandrasekaran A, Warsheski J, Chan K, Scatina J, Ermer J, Cevallos W, Sisenwine S: Metabolic disposition of bromfenac in healthy volunteers. Pharm Res 1995;12(suppl):S-372.
28. Tozer TN, Winter ME: Phenytoin. In, Evans WE, Schentag JJ. Jusko WJ (eds.): Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. Third edition. Spokane, Wash: Applied Therapeutics, 1992;25-1-25-44.